Effect of glucocorticoids on bone density

Qaiser Rehman, Nancy E Lane

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Glucocorticoid therapy is the most common cause of secondary iatrogenic osteoporosis. The bone loss occurs predominantly due to a decrease in bone formation, although increased bone resorption also occurs. Glucocorticoids induce osteoblast apoptosis and increase osteoclast survival and activity. Most of these effects are mediated through the RANKL/OPG system but perturbations in gonadal hormone activity and calcium balance may also contribute significantly to bone loss. Future therapies in the treatment and prevention of glucocorticoid-induced osteoporosis may be targeted at restoring the hormonal and cytokine balance to nullify the apoptotic effect of glucocorticoids on bone forming cells.

Original languageEnglish (US)
Pages (from-to)212-216
Number of pages5
JournalMedical and Pediatric Oncology
Volume41
Issue number3
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Bone Density
Glucocorticoids
Bone and Bones
Osteoporosis
Gonadal Hormones
Osteoclasts
Bone Resorption
Osteoblasts
Osteogenesis
Apoptosis
Cytokines
Calcium
Therapeutics

Keywords

  • Bone growth
  • Glucocorticoids
  • Osteoclasts
  • Osteoporosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Effect of glucocorticoids on bone density. / Rehman, Qaiser; Lane, Nancy E.

In: Medical and Pediatric Oncology, Vol. 41, No. 3, 01.09.2003, p. 212-216.

Research output: Contribution to journalArticle

Rehman, Qaiser ; Lane, Nancy E. / Effect of glucocorticoids on bone density. In: Medical and Pediatric Oncology. 2003 ; Vol. 41, No. 3. pp. 212-216.
@article{3bcdbb68b480437a8673fa7755049efc,
title = "Effect of glucocorticoids on bone density",
abstract = "Glucocorticoid therapy is the most common cause of secondary iatrogenic osteoporosis. The bone loss occurs predominantly due to a decrease in bone formation, although increased bone resorption also occurs. Glucocorticoids induce osteoblast apoptosis and increase osteoclast survival and activity. Most of these effects are mediated through the RANKL/OPG system but perturbations in gonadal hormone activity and calcium balance may also contribute significantly to bone loss. Future therapies in the treatment and prevention of glucocorticoid-induced osteoporosis may be targeted at restoring the hormonal and cytokine balance to nullify the apoptotic effect of glucocorticoids on bone forming cells.",
keywords = "Bone growth, Glucocorticoids, Osteoclasts, Osteoporosis",
author = "Qaiser Rehman and Lane, {Nancy E}",
year = "2003",
month = "9",
day = "1",
doi = "10.1002/mpo.10339",
language = "English (US)",
volume = "41",
pages = "212--216",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of glucocorticoids on bone density

AU - Rehman, Qaiser

AU - Lane, Nancy E

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Glucocorticoid therapy is the most common cause of secondary iatrogenic osteoporosis. The bone loss occurs predominantly due to a decrease in bone formation, although increased bone resorption also occurs. Glucocorticoids induce osteoblast apoptosis and increase osteoclast survival and activity. Most of these effects are mediated through the RANKL/OPG system but perturbations in gonadal hormone activity and calcium balance may also contribute significantly to bone loss. Future therapies in the treatment and prevention of glucocorticoid-induced osteoporosis may be targeted at restoring the hormonal and cytokine balance to nullify the apoptotic effect of glucocorticoids on bone forming cells.

AB - Glucocorticoid therapy is the most common cause of secondary iatrogenic osteoporosis. The bone loss occurs predominantly due to a decrease in bone formation, although increased bone resorption also occurs. Glucocorticoids induce osteoblast apoptosis and increase osteoclast survival and activity. Most of these effects are mediated through the RANKL/OPG system but perturbations in gonadal hormone activity and calcium balance may also contribute significantly to bone loss. Future therapies in the treatment and prevention of glucocorticoid-induced osteoporosis may be targeted at restoring the hormonal and cytokine balance to nullify the apoptotic effect of glucocorticoids on bone forming cells.

KW - Bone growth

KW - Glucocorticoids

KW - Osteoclasts

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=0042844488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042844488&partnerID=8YFLogxK

U2 - 10.1002/mpo.10339

DO - 10.1002/mpo.10339

M3 - Article

C2 - 12868121

AN - SCOPUS:0042844488

VL - 41

SP - 212

EP - 216

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -